Skip to main content
. 2016 Jul 29;34(35):4213–4220. doi: 10.1016/j.vaccine.2016.06.050

Table 2.

Financial costs of new vaccine introduction in Zambia (2014 US$).

MSD PCV RV Total Percent of total
Cold storage investments 228,515 505,663 1,207,044 1,941,223 46%
Social mobilisation 60,962 243,849 377,190 682,001 16%
Training 40,398 161,591 386,824 588,813 14%
Tally sheets and under-5 cards 157,773 157,773 157,773 473,320 11%
Post introduction evaluation 94,778 94,778 94,778 284,335 7%
Monitoring tools 32,876 131,505 76,918 241,300 6%
Total 615,304 1,295,161 2,300,528 4,210,992 100%



Costs per infant in birth cohort 0.96 2.02 3.58 6.56
Costs per capita 0.04 0.09 0.15 0.28

MSD: Measles second dose, PCV: Pneumococcal conjugate vaccine, RV: Rotavirus vaccine.